DBD Q1 2026 Earnings EPS Beats Estimates Shares Rise on Profitability Strength Intellia Therapeutics NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Market Optimism zSpace Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent ISSC Q1 2026 Earnings Strong EPS Beat Drives Optimism Despite Sparse Revenue Details BRKR Q1 2026 Earnings EPS Surges Past Estimates by Over 30 Atea Pharmaceuticals Q1 2026 Earnings Narrower Loss Surprises Analysts Amid RD Progress